ID

15117

Descripción

Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01508949

Link

https://clinicaltrials.gov/show/NCT01508949

Palabras clave

Versiones (1)
  1. 16/5/16 16/5/16 -
Subido en

16 de mayo de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes NCT01508949

Inglés

Eligibility Diabetes NCT01508949

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01508949
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes mellitus
Descripción

diabetes mellitus type 2

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0441730
diet treated and/or subjects in monotherapy with sulphonylurea or repaglinide
Descripción

diet therapy; sulphonylurea or repaglinide

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0012159
UMLS CUI [2]
C0038766
UMLS CUI [3]
C0246689
hba1c for diet treated subjects 6.5-12%, both inclusive
Descripción

hba1c

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019018
hba1c for sulphonylurea or repaglinide treated subjects maximum 10%
Descripción

hba1c for sulphonylurea or repaglinide treated subjects

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0038766
UMLS CUI [1,2]
C0019018
UMLS CUI [2,1]
C0246689
UMLS CUI [2,2]
C0019018
body mass index (bmi) at least 27 kg/m^2
Descripción

bmi

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1305855
euthyroid subjects
Descripción

euthyroid

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0117002
fasting blood glucose 7-14 mmol/l
Descripción

fasting blood glucose

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0428568
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
impaired liver function
Descripción

impaired liver function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0086565
impaired renal function
Descripción

impaired renal function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0151746
cardiac problems
Descripción

cardiac problems

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0262402
uncontrolled treated/untreated hypertension
Descripción

hypertension

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0020538
recurrent severe hypoglycaemia as judged by the investigator
Descripción

hypoglycaemia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0020615
known or suspected allergy to trial product or related products
Descripción

allergy to trial product

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0020517
use of any drug (except for ohas (oral hypoglycaemic agents), which in the investigator's opinion could interfere with the glucose level or body weight. stable doses, for 3 months or greater, of thyroid hormone replacement are allowed
Descripción

medication

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0202042
UMLS CUI [1,3]
C0005910
Volver a la parte superior de la página

Similar models

Eligibility Diabetes NCT01508949

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01508949
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
diabetes mellitus type 2
Item
type 2 diabetes mellitus
boolean
C0011849 (UMLS CUI [1,1])
C0441730 (UMLS CUI [1,2])
diet therapy; sulphonylurea or repaglinide
Item
diet treated and/or subjects in monotherapy with sulphonylurea or repaglinide
boolean
C0012159 (UMLS CUI [1])
C0038766 (UMLS CUI [2])
C0246689 (UMLS CUI [3])
hba1c
Item
hba1c for diet treated subjects 6.5-12%, both inclusive
boolean
C0019018 (UMLS CUI [1])
hba1c for sulphonylurea or repaglinide treated subjects
Item
hba1c for sulphonylurea or repaglinide treated subjects maximum 10%
boolean
C0038766 (UMLS CUI [1,1])
C0019018 (UMLS CUI [1,2])
C0246689 (UMLS CUI [2,1])
C0019018 (UMLS CUI [2,2])
bmi
Item
body mass index (bmi) at least 27 kg/m^2
boolean
C1305855 (UMLS CUI [1])
euthyroid
Item
euthyroid subjects
boolean
C0117002 (UMLS CUI [1])
fasting blood glucose
Item
fasting blood glucose 7-14 mmol/l
boolean
C0428568 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
impaired liver function
Item
impaired liver function
boolean
C0086565 (UMLS CUI [1])
impaired renal function
Item
impaired renal function
boolean
C0151746 (UMLS CUI [1])
cardiac problems
Item
cardiac problems
boolean
C0262402 (UMLS CUI [1])
hypertension
Item
uncontrolled treated/untreated hypertension
boolean
C0020538 (UMLS CUI [1])
hypoglycaemia
Item
recurrent severe hypoglycaemia as judged by the investigator
boolean
C0020615 (UMLS CUI [1])
allergy to trial product
Item
known or suspected allergy to trial product or related products
boolean
C0020517 (UMLS CUI [1])
medication
Item
use of any drug (except for ohas (oral hypoglycaemic agents), which in the investigator's opinion could interfere with the glucose level or body weight. stable doses, for 3 months or greater, of thyroid hormone replacement are allowed
boolean
C0013227 (UMLS CUI [1,1])
C0202042 (UMLS CUI [1,2])
C0005910 (UMLS CUI [1,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial